Download PDF
Semin Thromb Hemost
DOI: 10.1055/s-0044-1788324
Review Article

The Impact of Emotional Responses on Female Reproduction: Fibrinolysis in the Spotlight

Silvia Hoirisch-Clapauch
1   Hematology Department, Vascular Medicine, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Fibrinolytic enzymes modify various substrates required for tissue remodeling, playing a crucial role in mechanisms underlying resilience, reward processing, ovulation, embryo implantation, and placentation. Individuals with low resilience and reduced reward responsiveness, when exposed to chronic stress, are at increased risk of experiencing a range of negative emotions. Chronic anxiety and melancholia are examples of negative emotions associated with hypercortisolism, while fear and atypical depression are characterized by systemic inflammation. Both cortisol and inflammatory cytokines stimulate the production of plasminogen activator inhibitor-1 (PAI-1), a potent fibrinolysis inhibitor. Chronic anxiety, fear, and depression are among the many hypofibrinolytic conditions increasing the risk of oligo-anovulation, miscarriage, fetal growth restriction, and preeclampsia. Although significant, the impact of negative emotions on implantation is not as obvious as on ovulation or placentation. Other hypofibrinolytic conditions that may affect female reproduction through mechanisms dependent or independent of PAI-1 include metabolic disturbances (e.g., due to consumption of highly palatable foods, often used to alleviate negative affect), inflammation, hyperhomocysteinemia, hypothyroidism, hypercortisolism, antiphospholipid antibodies, and the 4G allele of the PAI-1 gene. Benzodiazepines and antidepressants should be used with caution in the first trimester as this combination may cause malformations. Also, selective serotonin reuptake inhibitors have fibrinolytic properties that increase the risk of bleeding after surgical procedures. Psychological interventions, especially group therapy, are effective in the prevention of reproductive disorders. Controlled trials are needed to test the hypothesis that female reproductive health depends on psychological well-being, a balanced diet and physical activity, suppression of inflammation and autoantibodies, and homocysteine and hormonal homeostasis.

Keywords

emotions - ovulation - embryo implantation - miscarriage - fetal growth restriction


Publication History

Article published online:
19 July 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Clifton J, Domar AD. Psychological distress and infertility: prevalence, impact, and interventions. In: Vaamonde D, Hackney AC, Garcia-Manso JM. eds. Fertility, Pregnancy, and Wellness. Amsterdam: Elsevier; 2022: 163-181
    Google Scholar
  • 2 Baack ML, Wang C, Hu S, Segar JL, Norris AW. Hyperglycemia induces embryopathy, even in the absence of systemic maternal diabetes: an in vivo test of the fuel mediated teratogenesis hypothesis. Reprod Toxicol 2014; 46: 129-136
    CrossrefPubMedGoogle Scholar
  • 3 de Jersey SJ, Nicholson JM, Callaway LK, Daniels LA. A prospective study of pregnancy weight gain in Australian women. Aust N Z J Obstet Gynaecol 2012; 52 (06) 545-551
    CrossrefPubMedGoogle Scholar
  • 4 Shahsavarani A, Abadi E, Kalkhoran M. Stress: facts and theories through literature review. Intern J Med Rev 2015; 2: 230-241
    PubMedGoogle Scholar
  • 5 McEwen BS. Central role of the brain in stress and adaptation. In: Fink G. ed. Stress: Concepts, Cognition, Emotion, and Behavior. San Diego, CA: Academic Press; 2016: 39-55
    Google Scholar
  • 6 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-5. Washington, DC: American Psychiatric Association; 2013
    CrossrefGoogle Scholar
  • 7 Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci 2007; 10 (09) 1089-1093
    CrossrefPubMedGoogle Scholar
  • 8 Irigoyen JP, Muñoz-Cánoves P, Montero L, Koziczak M, Nagamine Y. The plasminogen activator system: biology and regulation. Cell Mol Life Sci 1999; 56 (1–2): 104-132
    CrossrefPubMedGoogle Scholar
  • 9 Curry Jr TE, Smith MF. Impact of extracellular matrix remodeling on ovulation and the folliculo-luteal transition. Semin Reprod Med 2006; 24 (04) 228-241
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Laurenzi G, Fedeli V, Canipari R. Decreased fertility in female mice lacking urokinase plasminogen activator. Reprod Biol 2024; 24 (01) 100840
    CrossrefPubMedGoogle Scholar
  • 11 Rizov M, Andreeva P, Dimova I. Molecular regulation and role of angiogenesis in reproduction. Taiwan J Obstet Gynecol 2017; 56 (02) 127-132
    CrossrefPubMedGoogle Scholar
  • 12 Mazur P, Sokołowski G, Hubalewska-Dydejczyk A, Płaczkiewicz-Jankowska E, Undas A. Prothrombotic alterations in plasma fibrin clot properties in thyroid disorders and their post-treatment modifications. Thromb Res 2014; 134 (02) 510-517
    CrossrefPubMedGoogle Scholar
  • 13 Hori Y, Nakatani K, Morioka K. et al. Insulin enhanced thrombin-activable fibrinolysis inhibitor expression through PI3 kinase/Akt pathway. Int J Mol Med 2005; 15 (02) 265-268
    PubMedGoogle Scholar
  • 14 Vaughan DE. PAI-1 and atherothrombosis. J Thromb Haemost 2005; 3 (08) 1879-1883
    CrossrefPubMedGoogle Scholar
  • 15 Midorikawa S, Sanada H, Hashimoto S, Watanabe T. Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells. Biochem Biophys Res Commun 2000; 272 (01) 182-185
    CrossrefPubMedGoogle Scholar
  • 16 Antovic A, Bruzelius M. Impaired fibrinolysis in the antiphospholipid syndrome. Semin Thromb Hemost 2021; 47 (05) 506-511
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Tian R, Hou G, Li D, Yuan TF. A possible change process of inflammatory cytokines in the prolonged chronic stress and its ultimate implications for health. Sci World J 2014; 2014 (01) 780616
    PubMedGoogle Scholar
  • 18 Parmer RJ, Mahata M, Mahata S, Sebald MT, O'Connor DT, Miles LA. Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. J Biol Chem 1997; 272 (03) 1976-1982
    CrossrefPubMedGoogle Scholar
  • 19 Moons WG, Shields GS. Anxiety, not anger, induces inflammatory activity: an avoidance/approach model of immune system activation. Emotion 2015; 15 (04) 463-476
    CrossrefPubMedGoogle Scholar
  • 20 Qiu W, Cai X, Zheng C, Qiu S, Ke H, Huang Y. Update on the relationship between depression and neuroendocrine metabolism. Front Neurosci 2021; 15: 728810
    CrossrefPubMedGoogle Scholar
  • 21 Hoirisch-Clapauch S. Mechanisms affecting brain remodeling in depression: do all roads lead to impaired fibrinolysis?. Mol Psychiatry 2022; 27 (01) 525-533
    CrossrefPubMedGoogle Scholar
  • 22 Jamar G, Ribeiro DA, Pisani LP. High-fat or high-sugar diets as trigger inflammation in the microbiota-gut-brain axis. Crit Rev Food Sci Nutr 2021; 61 (05) 836-854
    CrossrefPubMedGoogle Scholar
  • 23 Fu XY, Chen HH, Zhang N. et al. Effects of chronic unpredictable mild stress on ovarian reserve in female rats: feasibility analysis of a rat model of premature ovarian failure. Mol Med Rep 2018; 18 (01) 532-540
    PubMedGoogle Scholar
  • 24 Zanettoullis AT, Mastorakos G, Vakas P, Vlahos N, Valsamakis G. Effect of stress on each of the stages of the IVF procedure: a systematic review. Int J Mol Sci 2024; 25 (02) 726
    CrossrefPubMedGoogle Scholar
  • 25 Klonoff-Cohen H, Chu E, Natarajan L, Sieber W. A prospective study of stress among women undergoing in vitro fertilization or gamete intrafallopian transfer. Fertil Steril 2001; 76 (04) 675-687
    CrossrefPubMedGoogle Scholar
  • 26 Dybciak P, Raczkiewicz D, Humeniuk E. et al. Depression in polycystic ovary syndrome: a systematic review and meta-analysis. J Clin Med 2023; 12 (20) 6446
    CrossrefPubMedGoogle Scholar
  • 27 Demyttenaere K, Nijs P, Evers-Kiebooms G, Koninckx PR. Coping and the ineffectiveness of coping influence the outcome of in vitro fertilization through stress responses. Psychoneuroendocrinology 1992; 17 (06) 655-665
    CrossrefPubMedGoogle Scholar
  • 28 Ny T, Wahlberg P, Brändström IJM. Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol Cell Endocrinol 2002; 187 (1–2): 29-38
    CrossrefPubMedGoogle Scholar
  • 29 Burchall GF, Piva TJ, Linden MD, Gibson-Helm ME, Ranasinha S, Teede HJ. Comprehensive assessment of the hemostatic system in polycystic ovarian syndrome. Semin Thromb Hemost 2016; 42 (01) 55-62
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Petríková J, Lazúrová I. Ovarian failure and polycystic ovary syndrome. Autoimmun Rev 2012; 11 (6–7): A471-A478
    CrossrefPubMedGoogle Scholar
  • 31 Li P, Shuai P, Shen S. et al. Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Med 2023; 21 (01) 302
    CrossrefPubMedGoogle Scholar
  • 32 Machado V, Escalda C, Proença L, Mendes JJ, Botelho J. Is there a bidirectional association between polycystic ovarian syndrome and periodontitis? A systematic review and meta-analysis. J Clin Med 2020; 9 (06) 1961
    CrossrefPubMedGoogle Scholar
  • 33 Alexandraki KI, Kaltsas GA. Endocrinopathies and other disorders inducing a polycystic ovary syndrome phenotype. In: Macut D, Pfeifer M, Yildiz BO, Diamanti-Kandarakis E. eds. Polycystic Ovary Syndrome. Novel Insights into Causes and Therapy. Basel: Karger; 2013. 40. 142-157
    Google Scholar
  • 34 Toulis KA, Goulis DG, Mintziori G. et al. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Hum Reprod Update 2011; 17 (06) 741-760
    CrossrefPubMedGoogle Scholar
  • 35 Liu Y, Sun MG, Jiang R. et al. Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis. J Assist Reprod Genet 2014; 31 (03) 363-370
    CrossrefPubMedGoogle Scholar
  • 36 Cimadomo D, Rienzi L, Conforti A. et al. Opening the black box: why do euploid blastocysts fail to implant? A systematic review and meta-analysis. Hum Reprod Update 2023; 29 (05) 570-633
    CrossrefPubMedGoogle Scholar
  • 37 Gottschall JA, Gottschall TA. Are per-incident rape-pregnancy rates higher than per-incident consensual pregnancy rates?. Hum Nat 2003; 14 (01) 1-20
    CrossrefPubMedGoogle Scholar
  • 38 Wilcox AJ, Dunson DB, Weinberg CR, Trussell J, Baird DD. Likelihood of conception with a single act of intercourse: providing benchmark rates for assessment of post-coital contraceptives. Contraception 2001; 63 (04) 211-215
    CrossrefPubMedGoogle Scholar
  • 39 Kondoh E, Okamoto T, Higuchi T. et al. Stress affects uterine receptivity through an ovarian-independent pathway. Hum Reprod 2009; 24 (04) 945-953
    CrossrefPubMedGoogle Scholar
  • 40 Purewal S, Chapman SCE, van den Akker OBA. Depression and state anxiety scores during assisted reproductive treatment are associated with outcome: a meta-analysis. Reprod Biomed Online 2018; 36 (06) 646-657
    CrossrefPubMedGoogle Scholar
  • 41 Peaston G, Subramanian V, Brunckhorst O, Sarris I, Ahmed K. The impact of emotional health on assisted reproductive technology outcomes: a systematic review and meta-analysis. Hum Fertil (Camb) 2022; 25 (03) 410-421
    CrossrefPubMedGoogle Scholar
  • 42 Nicoloro-SantaBarbara J, Busso C, Moyer A, Lobel M. Just relax and you'll get pregnant? Meta-analysis examining women's emotional distress and the outcome of assisted reproductive technology. Soc Sci Med 2018; 213: 54-62
    CrossrefPubMedGoogle Scholar
  • 43 Carmeliet P, Schoonjans L, Kieckens L. et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368 (6470): 419-424
    CrossrefPubMedGoogle Scholar
  • 44 Axelrod HR. Altered trophoblast functions in implantation-defective mouse embryos. Dev Biol 1985; 108 (01) 185-190
    CrossrefPubMedGoogle Scholar
  • 45 Azpiroz MA, Orguilia L, Palacio MI. et al. Potential biomarkers of infertility associated with microbiome imbalances. Am J Reprod Immunol 2021; 86 (04) e13438
    CrossrefPubMedGoogle Scholar
  • 46 Pacchiarotti A, Mohamed MA, Micara G. et al. The possible role of hyperhomocysteinemia on IVF outcome. J Assist Reprod Genet 2007; 24 (10) 459-462
    CrossrefPubMedGoogle Scholar
  • 47 Zeng H, He D, Hu L, Ma W, Quan S. PAI-1 4G/4G genotype is associated with recurrent implantation failure: a systematic review and meta-analysis. Reprod Sci 2021; 28 (11) 3051-3060
    CrossrefPubMedGoogle Scholar
  • 48 Denis AL, Guido M, Adler RD, Bergh PA, Brenner C, Scott Jr RT. Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients. Fertil Steril 1997; 67 (06) 1084-1090
    CrossrefPubMedGoogle Scholar
  • 49 Jungheim ES, Schon SB, Schulte MB, DeUgarte DA, Fowler SA, Tuuli MG. IVF outcomes in obese donor oocyte recipients: a systematic review and meta-analysis. Hum Reprod 2013; 28 (10) 2720-2727
    CrossrefPubMedGoogle Scholar
  • 50 Solberg H, Rinkenberger J, Danø K, Werb Z, Lund LR. A functional overlap of plasminogen and MMPs regulates vascularization during placental development. Development 2003; 130 (18) 4439-4450
    CrossrefPubMedGoogle Scholar
  • 51 Gris JC, Ripart-Neveu S, Maugard C. et al. Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. Thromb Haemost 1997; 77 (06) 1096-1103
    Article in Thieme ConnectPubMedGoogle Scholar
  • 52 Qu F, Wu Y, Zhu YH. et al. The association between psychological stress and miscarriage: a systematic review and meta-analysis. Sci Rep 2017; 7 (01) 1731
    CrossrefPubMedGoogle Scholar
  • 53 Magnus MC, Havdahl A, Morken NH, Wensaas KA, Wilcox AJ, Håberg SE. Risk of miscarriage in women with psychiatric disorders. Br J Psychiatry 2021; 219 (03) 501-506
    CrossrefPubMedGoogle Scholar
  • 54 Linna MS, Raevuori A, Haukka J, Suvisaari JM, Suokas JT, Gissler M. Reproductive health outcomes in eating disorders. Int J Eat Disord 2013; 46 (08) 826-833
    CrossrefPubMedGoogle Scholar
  • 55 Almeida ND, Basso O, Abrahamowicz M, Gagnon R, Tamblyn R. Risk of miscarriage in women receiving antidepressants in early pregnancy, correcting for induced abortions. Epidemiology 2016; 27 (04) 538-546
    CrossrefPubMedGoogle Scholar
  • 56 Fabozzi G, Cimadomo D, Maggiulli R. et al. Association between oocyte donors' or recipients' body mass index and clinical outcomes after first single blastocyst transfers-the uterus is the most affected. Fertil Steril 2024; 121 (02) 281-290
    CrossrefPubMedGoogle Scholar
  • 57 Liu Y, Chen H, Feng L, Zhang J. Interactions between gut microbiota and metabolites modulate cytokine network imbalances in women with unexplained miscarriage. NPJ Biofilms Microbiomes 2021; 7 (01) 24
    CrossrefPubMedGoogle Scholar
  • 58 Choi SE, Choudhary A, Ahern JM, Palmer N, Barrow JR. Association between maternal periodontal disease and adverse pregnancy outcomes: an analysis of claims data. Fam Pract 2021; 38 (06) 718-723
    PubMedGoogle Scholar
  • 59 Saadaoui M, Singh P, Ortashi O, Al Khodor S. Role of the vaginal microbiome in miscarriage: exploring the relationship. Front Cell Infect Microbiol 2023; 13: 1232825
    CrossrefPubMedGoogle Scholar
  • 60 Magnus MC, Morken NH, Wensaas KA, Wilcox AJ, Håberg SE. Risk of miscarriage in women with chronic diseases in Norway: a registry linkage study. PLoS Med 2021; 18 (05) e1003603
    CrossrefPubMedGoogle Scholar
  • 61 Nelen WLDM, Blom HJ, Steegers EAP, den Heijer M, Eskes TKAB. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 2000; 74 (06) 1196-1199
    CrossrefPubMedGoogle Scholar
  • 62 Zhang Y, Wang H, Pan X, Teng W, Shan Z. Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: a systematic review and meta-analysis. PLoS One 2017; 12 (04) e0175708
    CrossrefPubMedGoogle Scholar
  • 63 Gao R, Zeng R, Qing P. et al. Antiphospholipid antibodies and pregnancy outcome of assisted reproductive treatment: a systematic review and meta-analysis. Am J Reprod Immunol 2021; 86 (04) e13470
    CrossrefPubMedGoogle Scholar
  • 64 Wen Y, He H, Zhao K. Thrombophilic gene polymorphisms and recurrent pregnancy loss: a systematic review and meta-analysis. J Assist Reprod Genet 2023; 40 (07) 1533-1558
    CrossrefPubMedGoogle Scholar
  • 65 Iliodromiti S, Mackay DF, Smith GCS. et al. Customised and noncustomised birth weight centiles and prediction of stillbirth and infant mortality and morbidity: a cohort study of 979,912 term singleton pregnancies in Scotland. PLoS Med 2017; 14 (01) e1002228
    CrossrefPubMedGoogle Scholar
  • 66 Bussières EL, Tarabulsy GM, Pearson J, Tessier R, Forest JC, Giguère Y. Maternal prenatal stress and infant birth weight and gestational age: a meta-analysis of prospective studies. Dev Rev 2015; 36: 179-199
    CrossrefPubMedGoogle Scholar
  • 67 Al-Azemi M, Raghupathy R, Azizieh F. Pro-inflammatory and anti-inflammatory cytokine profiles in fetal growth restriction. Clin Exp Obstet Gynecol 2017; 44 (01) 98-103
    CrossrefPubMedGoogle Scholar
  • 68 Kırıcı P, Çağıran FT, Kalı Z, Tanrıverdi ES, Mavral N, Ecin SM. Determination of maternal serum pro-inflammatory cytokine changes in intrauterine growth restriction. Eur Rev Med Pharmacol Sci 2023; 27 (05) 1996-2001
    PubMedGoogle Scholar
  • 69 Ghimire U, Papabathini SS, Kawuki J, Obore N, Musa TH. Depression during pregnancy and the risk of low birth weight, preterm birth and intrauterine growth restriction- an updated meta-analysis. Early Hum Dev 2021; 152: 105243
    CrossrefPubMedGoogle Scholar
  • 70 Yang Z, Wang X, Wang M, Yan S, Wu F, Zhang F. Trajectory of prenatal anxiety and depression and its association with fetal growth development. Early Hum Dev 2023; 187: 105875
    CrossrefPubMedGoogle Scholar
  • 71 Shriyan P, Sudhir P, van Schayck OCP, Babu GR. Association of high cortisol levels in pregnancy and altered fetal growth. Results from the MAASTHI, a prospective cohort study, Bengaluru. Lancet Reg Health Southeast Asia 2023; 14: 100196
    CrossrefPubMedGoogle Scholar
  • 72 Reynolds LP, Vonnahme KA, Lemley CO. et al. Maternal stress and placental vascular function and remodeling. Curr Vasc Pharmacol 2013; 11 (05) 564-593
    CrossrefPubMedGoogle Scholar
  • 73 Castrogiovanni D, Alzamendi A, Ongaro L, Giovambattista A, Gaillard RC, Spinedi E. Fructose rich diet-induced high plasminogen activator inhibitor-1 (PAI-1) production in the adult female rat: protective effect of progesterone. Nutrients 2012; 4 (08) 1137-1150
    CrossrefPubMedGoogle Scholar
  • 74 Piccinni MP, Raghupathy R, Saito S, Szekeres-Bartho J. Cytokines, hormones and cellular regulatory mechanisms favoring successful reproduction. Front Immunol 2021; 12: 717808
    CrossrefPubMedGoogle Scholar
  • 75 Tanner LD, Brock And C, Chauhan SP. Severity of fetal growth restriction stratified according to maternal obesity. J Matern Fetal Neonatal Med 2022; 35 (10) 1886-1890
    CrossrefPubMedGoogle Scholar
  • 76 Carvalheiras G, Faria R, Braga J, Vasconcelos C. Fetal outcome in autoimmune diseases. Autoimmun Rev 2012; 11 (6–7): A520-A530
    CrossrefPubMedGoogle Scholar
  • 77 Hoirisch-Clapauch S. Silicone breast implants may contribute to early-onset fetal growth restriction. Clin Rheumatol 2023; 42 (09) 2445-2452
    CrossrefPubMedGoogle Scholar
  • 78 Tao Z, Chen Y, He F. et al. Alterations in the gut microbiome and metabolisms in pregnancies with fetal growth restriction. Microbiol Spectr 2023; 11 (03) e0007623
    CrossrefPubMedGoogle Scholar
  • 79 Ziaei S, Norrozi M, Faghihzadeh S, Jafarbegloo E. A randomised placebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin > or = 13.2 g/dl. BJOG 2007; 114 (06) 684-688
    CrossrefPubMedGoogle Scholar
  • 80 Díaz-Torres S, Díaz-López A, Arija V. Effect of prenatal iron supplementation adapted to hemoglobin levels in early pregnancy on fetal and neonatal growth—ECLIPSES Study. Nutrients 2024; 16 (03) 437
    CrossrefPubMedGoogle Scholar
  • 81 Xu J, Zhou F, Wang X, Mo C. Role of ferroptosis in pregnancy related diseases and its therapeutic potential. Front Cell Dev Biol 2023; 11: 1083838
    CrossrefPubMedGoogle Scholar
  • 82 Hogeveen M, Blom HJ, den Heijer M. Maternal homocysteine and small-for-gestational-age offspring: systematic review and meta-analysis. Am J Clin Nutr 2012; 95 (01) 130-136
    CrossrefPubMedGoogle Scholar
  • 83 Silva JF, Vidigal PN, Galvão DD. et al. Fetal growth restriction in hypothyroidism is associated with changes in proliferative activity, apoptosis and vascularisation of the placenta. Reprod Fertil Dev 2012; 24 (07) 923-931
    CrossrefPubMedGoogle Scholar
  • 84 Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK. Cushing's syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab 2005; 90 (05) 3077-3083
    CrossrefPubMedGoogle Scholar
  • 85 Xu J, Chen D, Tian Y, Wang X, Peng B. Antiphospholipid antibodies increase the risk of fetal growth restriction: a systematic meta-analysis. Int J Clin Pract 2022; 2022: 4308470
    PubMedGoogle Scholar
  • 86 Infante-Rivard C, Rivard GE, Guiguet M, Gauthier R. Thrombophilic polymorphisms and intrauterine growth restriction. Epidemiology 2005; 16 (03) 281-287
    CrossrefPubMedGoogle Scholar
  • 87 Said JM, Tsui R, Borg AJ. et al. The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women. J Thromb Haemost 2012; 10 (05) 881-886
    CrossrefPubMedGoogle Scholar
  • 88 Ye Y, Vattai A, Zhang X. et al. Role of plasminogen activator inhibitor type 1 in pathologies of female reproductive diseases. Int J Mol Sci 2017; 18 (08) 1651
    CrossrefPubMedGoogle Scholar
  • 89 Greenberg KI, Choi MJ. Understanding hypercoagulability with nephrotic syndrome: how the clot thickens. Clin J Am Soc Nephrol 2023; 18 (02) 149-151
    CrossrefPubMedGoogle Scholar
  • 90 Malyszko J, Skrzydlewska E, Malyszko JS, Myśliwiec M. Protein Z, a vitamin K-dependent protein in patients with renal failure. J Thromb Haemost 2003; 1 (01) 195-196
    CrossrefPubMedGoogle Scholar
  • 91 Ogawa M, Matsuda Y, Kobayashi A, Mitani M, Makino Y, Matsui H. Plasma antithrombin levels correlate with albumin and total protein in gestational hypertension and preeclampsia. Pregnancy Hypertens 2014; 4 (02) 174-177
    CrossrefPubMedGoogle Scholar
  • 92 Weenink GH, Treffers PE, Vijn P, Smorenberg-Schoorl ME, Ten Cate JW. Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. Am J Obstet Gynecol 1984; 148 (08) 1092-1097
    CrossrefPubMedGoogle Scholar
  • 93 Erez O, Hoppensteadt D, Romero R. et al. Preeclampsia is associated with low concentrations of protein Z. J Matern Fetal Neonatal Med 2007; 20 (09) 661-667
    CrossrefPubMedGoogle Scholar
  • 94 Nielsen LH, Kronborg C, Vittinghus E. et al. Is urinary excretion of plasminogen associated with development of pre-eclampsia? An observational, explorative case-control study. BMJ Open 2019; 9 (06) e026489
    CrossrefPubMedGoogle Scholar
  • 95 Baran Ö, Tuncer M, Nergiz Y, Akkuş M, Erdemoğlu M, Büyükbayram H. An increase of elastic tissue fibers in blood vessel walls of placental stem villi and differences in the thickness of blood vessel walls in third trimester pre-eclampsia pregnancies. Open Med 2010; 5 (02) 227-234
    CrossrefPubMedGoogle Scholar
  • 96 Agersnap I, Nissen PH, Hvas AM. The role of plasminogen activator inhibitor type 1 (PAI-1) in placenta-mediated pregnancy complications: a systematic review. Semin Thromb Hemost 2022; 48 (05) 607-624
    Article in Thieme ConnectPubMedGoogle Scholar
  • 97 Bodova KB, Biringer K, Dokus K, Ivankova J, Stasko J, Danko J. Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery Doppler velocimetry as markers of preeclampsia. Dis Markers 2011; 30 (04) 191-196
    CrossrefPubMedGoogle Scholar
  • 98 Qiu C, Williams MA, Calderon-Margalit R, Cripe SM, Sorensen TK. Preeclampsia risk in relation to maternal mood and anxiety disorders diagnosed before or during early pregnancy. Am J Hypertens 2009; 22 (04) 397-402
    CrossrefPubMedGoogle Scholar
  • 99 Almasi-Hashiani A, Omani-Samani R, Mohammadi M. et al. Assisted reproductive technology and the risk of preeclampsia: an updated systematic review and meta-analysis. BMC Pregnancy Childbirth 2019; 19 (01) 149
    CrossrefPubMedGoogle Scholar
  • 100 Paula WO, Patriota ESO, Gonçalves VSS, Pizato N. Maternal consumption of ultra-processed foods-rich diet and perinatal outcomes: a systematic review and meta-analysis. Nutrients 2022; 14 (15) 3242
    CrossrefPubMedGoogle Scholar
  • 101 Gallos ID, Sivakumar K, Kilby MD, Coomarasamy A, Thangaratinam S, Vatish M. Pre-eclampsia is associated with, and preceded by, hypertriglyceridaemia: a meta-analysis. BJOG 2013; 120 (11) 1321-1332
    CrossrefPubMedGoogle Scholar
  • 102 Xiong Z, Wang Q, Pei S, Zhu Z. The causal role of intestinal microbiome in development of pre-eclampsia. Funct Integr Genomics 2023; 23 (02) 127
    CrossrefPubMedGoogle Scholar
  • 103 He XJ, Dai RX, Hu CL. Maternal prepregnancy overweight and obesity and the risk of preeclampsia: a meta-analysis of cohort studies. Obes Res Clin Pract 2020; 14 (01) 27-33
    CrossrefPubMedGoogle Scholar
  • 104 Hu H, Ha S, Roth J, Kearney G, Talbott EO, Xu X. Ambient air pollution and hypertensive disorders of pregnancy: a systematic review and meta-analysis. Atmos Environ 2014; 97: 336-345
    CrossrefPubMedGoogle Scholar
  • 105 Dong Y, Yuan F, Dai Z, Wang Z, Zhu Y, Wang B. Preeclampsia in systemic lupus erythematosus pregnancy: a systematic review and meta-analysis. Clin Rheumatol 2020; 39 (02) 319-325
    CrossrefPubMedGoogle Scholar
  • 106 Köcher L, Rossides M, Remaeus K. et al. Maternal and infant outcomes in sarcoidosis pregnancy: a Swedish population-based cohort study of first births. Respir Res 2020; 21 (01) 225
    CrossrefPubMedGoogle Scholar
  • 107 Conde-Agudelo A, Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol 2022; 226 (01) 68-89.e3
    CrossrefPubMedGoogle Scholar
  • 108 Nourollahpour Shiadeh M, Behboodi Moghadam Z, Adam I, Saber V, Bagheri M, Rostami A. Human infectious diseases and risk of preeclampsia: an updated review of the literature. Infection 2017; 45 (05) 589-600
    CrossrefPubMedGoogle Scholar
  • 109 Shan Y, Guan C, Wang J, Qi W, Chen A, Liu S. Impact of ferroptosis on preeclampsia: a review. Biomed Pharmacother 2023; 167: 115466
    CrossrefPubMedGoogle Scholar
  • 110 Zhang C, Hu J, Wang X, Gu H. High level of homocysteine is associated with pre-eclampsia risk in pregnant woman: a meta-analysis. Gynecol Endocrinol 2022; 38 (09) 705-712
    CrossrefPubMedGoogle Scholar
  • 111 Hajifoghaha M, Teshnizi SH, Forouhari S, Dabbaghmanesh MH. Association of thyroid function test abnormalities with preeclampsia: a systematic review and meta-analysis. BMC Endocr Disord 2022; 22 (01) 240
    CrossrefPubMedGoogle Scholar
  • 112 Caimari F, Valassi E, Garbayo P. et al. Cushing's syndrome and pregnancy outcomes: a systematic review of published cases. Endocrine 2017; 55 (02) 555-563
    CrossrefPubMedGoogle Scholar
  • 113 Walter IJ, Klein Haneveld MJ, Lely AT, Bloemenkamp KWM, Limper M, Kooiman J. Pregnancy outcome predictors in antiphospholipid syndrome: a systematic review and meta-analysis. Autoimmun Rev 2021; 20 (10) 102901
    CrossrefPubMedGoogle Scholar
  • 114 Zhao L, Bracken MB, Dewan AT, Chen S. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis. Mol Hum Reprod 2013; 19 (03) 136-143
    CrossrefPubMedGoogle Scholar
  • 115 Wang X, Khalil RA. Matrix metalloproteinases, vascular remodeling, and vascular disease. In: Raouf A. Khalil, ed. Advances in Pharmacology. Vol. 18. Cambridge, MA: Academic Press; 2018: 241-330
    Google Scholar
  • 116 Atiomo WU, Bates SA, Condon JE, Shaw S, West JH, Prentice AG. The plasminogen activator system in women with polycystic ovary syndrome. Fertil Steril 1998; 69 (02) 236-241
    CrossrefPubMedGoogle Scholar
  • 117 Targher G, Zoppini G, Bonora E, Moghetti P. Hemostatic and fibrinolytic abnormalities in polycystic ovary syndrome. Semin Thromb Hemost 2014; 40 (05) 600-618
    Article in Thieme ConnectPubMedGoogle Scholar
  • 118 Martínez-Zamora MA, Creus M, Tassies D. et al. Reduced plasma fibrinolytic potential in patients with recurrent implantation failure after IVF and embryo transfer. Hum Reprod 2011; 26 (03) 510-516
    CrossrefPubMedGoogle Scholar
  • 119 Rai R, Tuddenham E, Backos M. et al. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum Reprod 2003; 18 (12) 2540-2543
    CrossrefPubMedGoogle Scholar
  • 120 Marchi R, López Ramirez Y, Nagaswami C. et al. Haemostatic changes related to fibrin formation and fibrinolysis during the first trimester in normal pregnancy and in recurrent miscarriage. Thromb Haemost 2007; 97 (04) 552-557
    Article in Thieme ConnectPubMedGoogle Scholar
  • 121 Wang M, Hu Z, Cheng QX, Xu J, Liang C. The ability of thromboelastography parameters to predict severe pre-eclampsia when measured during early pregnancy. Int J Gynaecol Obstet 2019; 145 (02) 170-175
    CrossrefPubMedGoogle Scholar
  • 122 Ohnishi J, Ohnishi E, Shibuya H, Takahashi T. Functions for proteinases in the ovulatory process. Biochim Biophys Acta 2005; 1751 (01) 95-109
    CrossrefPubMedGoogle Scholar
  • 123 Qu H, Khalil RA. Role of ADAM and ADAMTS disintegrin and metalloproteinases in normal pregnancy and preeclampsia. Biochem Pharmacol 2022; 206: 115266
    CrossrefPubMedGoogle Scholar
  • 124 El-Osta A, Brasacchio D, Yao D. et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008; 205 (10) 2409-2417
    CrossrefPubMedGoogle Scholar
  • 125 Rajaram S, Gupta V, Gupta B. Unexplained recurrent miscarriage: a dilemma. In: Mehta S, Gupta B. Eds. Recurrent Pregnancy Loss. Singapore: Springer; 2018: 149-156
    Google Scholar
  • 126 Bian C, Cao J, Chen K, Xia X, Yu X. Effectiveness of psychological interventions on pregnancy rates in infertile women undergoing assisted reproductive technologies: a meta-analysis of randomised controlled trials. Biotechnol Genet Eng Rev 2023; 1-20
    CrossrefPubMedGoogle Scholar
  • 127 Warne E, Oxlad M, Best T. Evaluating group psychological interventions for mental health in women with infertility undertaking fertility treatment: a systematic review and meta-analysis. Health Psychol Rev 2023; 17 (03) 377-401
    CrossrefPubMedGoogle Scholar
  • 128 Grigoriadis S, Graves L, Peer M. et al. Benzodiazepine use during pregnancy alone or in combination with an antidepressant and congenital malformations: systematic review and meta-analysis. J Clin Psychiatry 2019; 80 (04) 1845
    CrossrefPubMedGoogle Scholar
  • 129 Teede HJ, Misso ML, Costello MF. et al; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2018; 89 (03) 251-268
    CrossrefPubMedGoogle Scholar
  • 130 Doutremepuich C, Deharo E, Doutremepuich F, Lalanne MC, Toulemonde F. Kinetic study of tPA release induced by heparin and heparin fragment. Thromb Res 1989; 53 (06) 615-621
    CrossrefPubMedGoogle Scholar
  • 131 Tiscia GL, De Laurenzo A, Cappucci F. et al. Thromboelastography parameters in Italian pregnant women: do antithrombotic drugs change reference values?. J Investig Med 2020; 68 (04) 902-905
    CrossrefPubMedGoogle Scholar
  • 132 Hoirisch-Clapauch S, Nardi AE. Autism spectrum disorders: let's talk about glucose?. Transl Psychiatry 2019; 9 (01) 51
    CrossrefPubMedGoogle Scholar
  • 133 Yan YS, Feng C, Yu DQ. et al. Long-term outcomes and potential mechanisms of offspring exposed to intrauterine hyperglycemia. Front Nutr 2023; 10: 1067282
    CrossrefPubMedGoogle Scholar
  • 134 Hu Z, Gao R, Huang W, Wang H, Qin L. Effect of hydroxychloroquine on lupus activity, preeclampsia and intrauterine growth restriction in pregnant women with systemic lupus erythematosus and/or antiphospholipid syndrome: a systematic review and meta-analysis. J Clin Med 2023; 12 (02) 485
    CrossrefPubMedGoogle Scholar